MiRNAs related to KRAS mutational status in resectable non-small cell lung cancer

被引：0
|
作者：
Gallach, S. [1 ]
Calabuig-Farinas, S. [1 ]
Jantus-Lewintre, E. [1 ]
Montaner, D. [2 ]
Escorihuela, E. [1 ]
Castellano, J. [1 ]
Figueroa, S. [3 ]
Blasco, A. [4 ]
Hernando, C. [4 ]
Guijarro, R. [5 ]
Camps, C. [5 ]
机构：
[1] Fdn Invest Hosp Gen Valencia, Valencia, Spain
[2] Ctr Invest Principe Felipe, Dept Bioinformat, Valencia, Spain
[3] Consorcio Hosp Gen Univ Valencia, Serv Cirugia Torac, Valencia, Spain
[4] Consorcio Hosp Gen Univ Valencia, Serv Oncol Med, Valencia, Spain
[5] Univ Valencia, Dept Med, Valencia, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70671-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
545
引用
收藏
页码：177 / 177
页数：1
相关论文
共 50 条
  • [1] Prognostic role of miRNAs in resectable non-small cell lung cancer
    Gallach, Sandra
    Jantus-Lewintre, Eloisa
    Calabuig-Fariarinas, Silvia
    Blasco, Ana
    Guijarro, Ricardo
    Martorell, Miguel
    Camps, Carlos
    CANCER RESEARCH, 2015, 75
  • [2] Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?
    Macerelli, M.
    Caramella, C.
    Faivre, L.
    Besse, B.
    Planchard, D.
    Polo, V.
    Camus, M. Ngo
    Celebic, A.
    Koubi-Pick, V.
    Lacroix, L.
    Pignon, J. P.
    Soria, J. C.
    LUNG CANCER, 2014, 83 (03) : 383 - 388
  • [3] KRAS in non-small cell lung cancer
    Amanam, I.
    Gupta, R.
    Mambetsariev, I.
    Koczywas, M.
    Cristea, M.
    Massarelli, E.
    Reckamp, K. L.
    Salgia, R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [4] OVERALL SURVIVAL AND SMOKING STATUS IN RESECTABLE NON-SMALL CELL LUNG CANCER
    Spain, Lavinia
    Walkiewicz, Marzena
    Knight, Simon
    Mitchell, Paul
    John, Thomas
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S629 - S629
  • [5] KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer
    I. Sullivan
    J. Salazar
    C. Arqueros
    M. Andrés
    A. Sebio
    M. Majem
    J. Szafranska
    E. Martínez
    D. Páez
    A. López-Pousa
    M. Baiget
    A. Barnadas
    Clinical and Translational Oncology, 2017, 19 : 884 - 890
  • [6] KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer
    Sullivan, I.
    Salazar, J.
    Arqueros, C.
    Andres, M.
    Sebio, A.
    Majem, M.
    Szafranska, J.
    Martinez, E.
    Paez, D.
    Lopez-Pousa, A.
    Baiget, M.
    Barnadas, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (07): : 884 - 890
  • [7] Mutational status of non-small cell lung cancer in Portugal: A multicentric study
    Duarte, J. A.
    Silva, D. N.
    Mendes, J. L.
    Ferreira, R. Q.
    Montenegro, M. A.
    Vicente, R. S.
    Mendes, A. Duarte
    Freitas, R. R.
    Martins, T. S.
    Silva, B. M.
    Machete, M.
    Fortuna, A. R.
    das Neves, R. Correia
    Correia, J.
    Simoes, P.
    Moreira-Pinto, J.
    Timoteo, T.
    Passos-Coelho, J. L. C.
    ANNALS OF ONCOLOGY, 2023, 34 : S1141 - S1141
  • [8] Chemotherapy in resectable non-small cell lung cancer
    Enriqueta Felip
    Revista de Oncología, 2004, 6 (1): : 52 - 56
  • [9] EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells
    Stella, Giulia M.
    Scabini, Roberta
    Inghilleri, Simona
    Cemmi, Francesca
    Corso, Simona
    Pozzi, Ernesto
    Morbini, Patrizia
    Valentini, Adele
    Dore, Roberto
    Ferrari, Simona
    Luisetti, Maurizio
    Zorzetto, Michele
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (08) : 1327 - 1335
  • [10] EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells
    Giulia M. Stella
    Roberta Scabini
    Simona Inghilleri
    Francesca Cemmi
    Simona Corso
    Ernesto Pozzi
    Patrizia Morbini
    Adele Valentini
    Roberto Dore
    Simona Ferrari
    Maurizio Luisetti
    Michele Zorzetto
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1327 - 1335
12345